Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia

To overcome the drug resistance phenomenon induced by Imatibib (IM), in clinical practice, are often used second generation of tyrosine kinase inhibitors as Nilotinib (NIL); a such potent inhibitor of the BCR/ABL kinase and Dasatinib (DAS), a inhibitor of BCR/ABL kinase, and inhibitor SrC family kinase. In this study we evaluated the in vivo effect of DAS, NIL, and IM on intracellular calcium concentration, oxidative stress, and apoptosis in peripheral blood leukocytes of 45 newly diagnosed patients with chronic myeloid leukaemia (CML‐PBM). Our data demonstrated that treatment with DAS and NIL showed an higher modulating potential than IM on intracellular calcium concentration by inhibiting the thapsigargin, a sarcoplasmic/endoplasmic reticulum Ca2+‐ATPase (SERCA) inhibitor, and Lithium (Li) an inositol 1,4,5‐triphosphate (InsP3) receptor inhibitor activities. Moreover our data demonstrated that NIL and DAS have significantly increased apoptosis more than IM by involving both intracellular calcium signaling as well as oxidative stress. The acquisition of the oxidative stress and calcium channels receptors values data could help the hematologist to modulate and improve the treatment of chronic myeloid leukaemia (CML) pathology. J. Cell. Physiol. 231: 680–687, 2016. © 2015 Wiley Periodicals, Inc.

[1]  Zhifeng Liu,et al.  Heat Stress Induces Apoptosis through a Ca2+-Mediated Mitochondrial Apoptotic Pathway in Human Umbilical Vein Endothelial Cells , 2014, PloS one.

[2]  Keita Ito,et al.  Imatinib-associated tumour response in a dog with a non-resectable gastrointestinal stromal tumour harbouring a c-kit exon 11 deletion mutation. , 2013, Veterinary journal.

[3]  A. Giordano,et al.  Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells , 2013, Cell cycle.

[4]  F. Liu,et al.  Oridonin induces apoptosis and senescence by increasing hydrogen peroxide and glutathione depletion in colorectal cancer cells , 2012, International journal of molecular medicine.

[5]  Siddhartha Roy,et al.  Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance , 2012, Cancer science.

[6]  Y. Ho,et al.  Arsenic trioxide and radiation enhance apoptotic effects in HL-60 cells through increased ROS generation and regulation of JNK and p38 MAPK signaling pathways. , 2011, Chemico-biological interactions.

[7]  A. Giordano,et al.  Dysregulated calcium homeostasis and oxidative stress in chronic myeloid leukemia (CML) cells , 2010, Journal of cellular physiology.

[8]  Susan O'Brien,et al.  Results of dasatinib therapy in patients with early chronic-phase chronic myeloid leukemia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  M. Dyer,et al.  Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. , 2009, The Journal of clinical investigation.

[10]  Martin C. Müller,et al.  Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. , 2008, Blood.

[11]  H. Kantarjian,et al.  Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy. , 2007, Blood.

[12]  Andreas Hochhaus,et al.  Chronic myeloid leukaemia , 2007, The Lancet.

[13]  K. Hellstrand,et al.  Cutting Edge: Antioxidative Properties of Myeloid Dendritic Cells: Protection of T Cells and NK Cells from Oxygen Radical-Induced Inactivation and Apoptosis1 , 2007, The Journal of Immunology.

[14]  S. Waxman,et al.  Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors. , 2006, Cancer research.

[15]  M. Pozo,et al.  Mitochondrial reactive oxygen species and Ca2+ signaling. , 2006, American journal of physiology. Cell physiology.

[16]  A. Hochhaus,et al.  Chronic myelogenous leukemia (CML): resistance to tyrosine kinase inhibitors. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  Simona Soverini,et al.  Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. , 2006, Blood.

[18]  D. Giustarini,et al.  Oxidized forms of glutathione in peripheral blood as biomarkers of oxidative stress. , 2006, Clinical chemistry.

[19]  Donna Neuberg,et al.  Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. , 2005, Cancer cell.

[20]  Ping Chen,et al.  Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. , 2004, Journal of medicinal chemistry.

[21]  I. Sergeev.  Genistein induces Ca2+ -mediated, calpain/caspase-12-dependent apoptosis in breast cancer cells. , 2004, Biochemical and biophysical research communications.

[22]  A. Hochhaus,et al.  Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance , 2004, Leukemia.

[23]  Ping Chen,et al.  Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor , 2004, Science.

[24]  A. Giordano,et al.  MPA increases idarubicin‐induced apoptosis in chronic lymphatic leukaemia cells via caspase‐3 , 2003, Journal of cellular biochemistry.

[25]  M. Madesh,et al.  Calcium signaling and apoptosis. , 2003, Biochemical and biophysical research communications.

[26]  K. Nakanishi,et al.  An Endoplasmic Reticulum Stress-specific Caspase Cascade in Apoptosis , 2002, The Journal of Biological Chemistry.

[27]  H. Forman,et al.  Cellular glutathione and thiols metabolism. , 2002, Biochemical pharmacology.

[28]  T. Cotter,et al.  High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion , 2002, Leukemia.

[29]  A. D. Van den Abbeele,et al.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. , 2002, The New England journal of medicine.

[30]  M. Baccarani,et al.  Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. , 2002, The New England journal of medicine.

[31]  S. Pervaiz,et al.  Activation of the RacGTPase inhibits apoptosis in human tumor cells , 2001, Oncogene.

[32]  A. Jackson,et al.  The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. , 2001, Mutation research.

[33]  C. Sawyers.  Chronic myeloid leukemia. , 1999, The New England journal of medicine.

[34]  T. Jabs.  Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. , 1999, Biochemical pharmacology.

[35]  S. Pervaiz,et al.  Apoptosis induced by hydrogen peroxide is mediated by decreased superoxide anion concentration and reduction of intracellular milieu , 1998, FEBS letters.

[36]  G Inesi,et al.  Use of thapsigargin to study Ca2+ homeostasis in cardiac cells , 1995, Bioscience reports.

[37]  C. Tzeng,et al.  Cytogenetic studies in de novo acute nonlymphocytic leukemia. , 1995, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

[38]  G. Murrell,et al.  Modulation of fibroblast proliferation by oxygen free radicals , 1990 .

[39]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[40]  C. McCall,et al.  Independent stimulation of motility and the oxidative metabolic burst of human polymorphonuclear leukocytes. , 1978, Journal of immunology.

[41]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[42]  M. Pozo,et al.  Mitochondrial reactive oxygen species and Ca 2 signaling , 2006 .

[43]  T. Buttke,et al.  Oxidative stress as a mediator of apoptosis. , 1994, Immunology today.

[44]  H. Esterbauer,et al.  Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. , 1990, Methods in enzymology.

[45]  R. Kretsinger.  The informational role of calcium in the cytosol. , 1979, Advances in cyclic nucleotide research.